TCL Archive In Brief: Columbia’s Marks Reportedly Will Move To MSK; FDA Committee to Consider THC For Group C List May 23, 1980
TCL Archive FDA, CMS Take Second Look at Drugs Given “Accelerated” Approval for Cancer February 21, 2003
TCL Archive US Oncology Renegotiates Affiliations, Converts Practices To Earnings Model. November 30, 2001
TCL Archive Genentech Reps Not Welcome: Hospitals Urge Drug Maker to Reverse Policy On Supplying Avastin, Rituxan, & Herceptin October 17, 2014
